5G-PEARL: Paxalisib in Malignant Brain Tumours

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Malignant Primary Gliomas · Glioblastoma Multiforme (GBM)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Royal Marden NHS Foundation Trust, Sutton, United Kingdom
Contact: Study coordinator (Juanita Lopez, MD, PhD) · juanita.lopez@icr.ac.uk · +44 (0)20 86613539

Study leads

Juanita Lopez, MD, PhD
Study Director
National Health Service, United Kingdom

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours

Glioblastoma Multiforme (GBM) · Glioblastoma Multiform (Grade IV Astrocytoma) · Diffuse Hemispheric Glioma, H3 G34-Mutant

Abroad (travel likely)RecruitingPHASE1, PHASE2

Cambridge, United Kingdom · Sutton, United Kingdom

5G-EMERALD: Amivantamab in Malignant Brain Tumours

Malignant Primary Gliomas · Glioblastoma Multiform (Grade IV Astrocytoma) · Diffuse Hemispheric Glioma, H3 G34-Mutant

Abroad (travel likely)RecruitingPHASE1

Cambridge, United Kingdom · Sutton, United Kingdom

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Amyloidosis · Basal Cell Carcinoma · Biliary Tract Carcinoma

Abroad (travel likely)RecruitingPHASE2

Jacksonville, United States

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

Diffuse Midline Glioma (DMG) · Glioblastoma · Recurrent Ependymoma

Abroad (travel likely)RecruitingPHASE1

San Francisco, United States · Washington D.C., United States